Advancing Orthopedic
Extremity Implants
Innovations for critical gaps in orthopedic extremity implant surgery.
Improving Orthopedic Outcomes
As the population ages, osteoarthritis is becoming a major driver of mobility loss for millions worldwide. We develop advanced joint replacement solutions positioned to address this growing market need while restoring function and improving quality of life.
The Problem
Thumb CMC Osteoarthritis (OA)
Our Team
Rick Thomson
President and CEO
Nathan T. Morrell, MD, FAOA
Chief Medical Officer
Dimitri Madden
Chief Operating Officer
Ethan Darwin
Chief R&D Officer
Introducing ZEPARTTM
Our revolutionary implant designed to meet growing needs for a stable, functional and reliable thumb CMC joint replacement. Developed by renowned U.S. hand surgeon Nathan T. Morrell with our expert science and engineering team.
The implant shown has not yet received FDA clearance, nor CE marking. It is not available for sale in the US nor Europe.
Sandia Medical Technologies is an emerging AI-enabled leader for orthopedic extremity surgery.
CMC thumb joint osteoarthritis affects millions, with cases rising exponentially each year in an aging population. ZEPARTTM offers a new solution for patients who seek operative treatment in the U.S., and the countless more considering treatment.
